LL-37 vs KPV
LL-37 is the only human cathelicidin antimicrobial peptide, a 37-amino-acid fragment cleaved from the hCAP-18 precursor protein. Beyond its broad-spectrum antimicrobial activity against bacteria, fungi, and enveloped viruses, LL-37 functions as a significant immunomodulatory molecule. Preclinical studies have documented its effects on wound closure, angiogenesis, and modulation of NF-kB-mediated inflammatory cascades. KPV is a tripeptide (Lys-Pro-Val) derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH). Its primary mechanism of interest involves direct inhibition of the NF-kB inflammatory signaling pathway, which plays a central role in intestinal and tissue inflammation. KPV retains the anti-inflammatory properties of full-length alpha-MSH without engaging melanocortin receptors, making it a focused tool for studying NF-kB-driven inflammatory processes.
LL-37
KPV
The Verdict
LL-37 and KPV both appear in immune and inflammation research but operate through fundamentally different mechanisms. LL-37 functions as both a direct antimicrobial agent and an immunomodulatory signal, making it valuable in study models involving microbial challenge. KPV is a focused NF-kB pathway inhibitor without antimicrobial activity, making it more precise for studying inflammation independent of infection. Researchers studying complex wound or gut environments may use both to address structural defense and inflammatory regulation simultaneously.
Explore These Products
LL-37
A 37-amino acid antimicrobial peptide and the only human cathelicidin, studied for broad-spectrum antimicrobial activity, immune modulation, and wound healing.
View Details →KPV
A tripeptide (Lys-Pro-Val) derived from alpha-MSH studied for its potent anti-inflammatory properties through NF-κB signaling inhibition.
View Details →LL-37 vs KPV — FAQ
Is LL-37 only an antimicrobial peptide?
How does KPV inhibit inflammation?
Can they be studied together?
What is the regulatory status?
References
Primary sources for key clinical and regulatory claims on this page.
- LL-37, the only human member of the cathelicidin family of antimicrobial peptides — PubMed / Biochim Biophys Acta . Foundational review of LL-37 antimicrobial and immunomodulatory functions.
- KPV, an alpha-MSH tripeptide analogue, attenuates murine colitis — PubMed / J Pharmacol Exp Ther . Key preclinical source demonstrating KPV anti-inflammatory activity via NF-kB inhibition.
Keep Researching
Use the surrounding category and guide pages to move from a side-by-side comparison into the broader decision path.